Penumbra Announces Pricing Of Offering Of 1,300,000 Shares Of Its Common Stock Post author:Sam Post published:March 16, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like This is What Happens When the FDA Approves Cancer Drugs Too Quickly August 16, 2017 Biotech Bestie Celgene Takes Stake, Inks $1 Billion+ Deal With BeiGene July 5, 2017 Biogen's Early-Stage Alzheimer's Data Continues to Impress November 1, 2017